logo
logo

BrainSightAI raised $5M in Pre-Series A funding led by IAN Alpha Fund to expand its presence in Tier I and II cities and pursue FDA certification for entry into the US.

BrainSightAI raised $5M in Pre-Series A funding led by IAN Alpha Fund to expand its presence in Tier I and II cities and pursue FDA certification for entry into the US.

01/08/25, 11:58 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/IN.svgbengaluru
Money raised
$5 million
Industry
artificial intelligence
health care
Round Type
series a
Investors
Silver Needle, Ivy Cap Ventures, Ian Alpha Fund
Bengaluru-based BrainSightAI has successfully raised $5 million in Pre-Series A funding, led by IAN Alpha Fund. The capital will be used to scale operations, seek FDA certification, and develop a caregiver-focused app.

Company Info

Company
BrainSightAI
Location
bengaluru, karnataka, india
Additional Info
BrainSightAI combines artificial intelligence and neuroscience to enable greater precision in neurological and psychiatric investigation for accelerated patient outcomes. We currently provide two AI based solutions, Voxelbox and Snowdrop. Voxelbox provides clinicians with access to a world-class fMRI processing engine and machine-learning models for generating reports to aid clinical decision making. Snowdrop Patient care app that enables compliance with treatment schedule and build a holistic patient profile between visits with reports triangulated from patients, caregivers and our AI engine.

Related People